Skip to content

Evaluation of clinical efficacy of anti-infection strategies for lung transplantation based on mNGS

Evaluation of clinical efficacy of anti-infection strategies for lung transplantation based on mNGS

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111574
Enrollment
Unknown
Registered
2025-11-03
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative pulmonary infection

Interventions

Anti-infection strategies based on metagenomic next-generation sequencing (mNGS) group:NA
Empiric anti-infective strategy group:NA

Sponsors

Wuxi People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Lung transplant recipients who underwent lung transplantation in Wuxi People's Hospital from 2015.01.01 to 2022.07.31 were enrolled in the study;

Exclusion criteria

Exclusion criteria: 1. Recipients were less than 18 years old at the time of lung transplant; 2. Recipients who underwent retransplant; 3. History of other solid organ transplants; 4. Recipient died within 72 hours of lung transplantation; 5. Patients with serious lack of data on lung transplant recipients;

Design outcomes

Primary

MeasureTime frame
Hospital mortality;

Secondary

MeasureTime frame
Cumulative survival rate;

Countries

China

Contacts

Public ContactXiaoshan Li

Wuxi People’s Hospital

sclxs87@163.com+86 510 8535 0386

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026